ISRCTN72038467进行中（未招募）未知
Evaluating the Population Impact of hepatitis C direct-acting antiviral Treatment as Prevention for people who inject drugs: a non-randomised trial
niversity of Dundee0 个研究点目标入组 555 人开始时间: 2019年1月24日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 555
研究概览
简要总结
2019 Protocol article in https://pubmed.ncbi.nlm.nih.gov/31551376/ (added 15/09/2021)
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •1. HCV diagnosis
- •2. Injecting drug use
- •3. Aged 18 years or over
排除标准
- •1. Mental health or behavioural problems e.g. psychosis, aggressiveness.
研究者
相似试验
已完成
不适用
STOP HCV-1 – Stratified Treatment Optimisation for HCV-1ISRCTN37915093Imperial College London202
已完成
不适用
Hepatitis C Rimantadine and Antiviral Combination TherapyHepatitis CNCT01413490The Leeds Teaching Hospitals NHS Trust10
Unknown
不适用
Epidemiology of Hepatitis C Virus Infection Among Opioid Substituted PatientsHepatitis CNCT02395198Prof. Dr. med. Jens Reimer2,467
Unknown
3 期
Assessment Effects After Direct Acting Antiviral in Chronic Hepatitis c Virus PatientsChronic Hepatitis cNCT03163849Assiut University50
招募中
不适用
The Efficacy of Vosevi in Treating DAA-experienced PatientsChronic Hepatitis CMedication ReactionNCT06180590The Third Affiliated Hospital of Guangzhou Medical University200